Analystreport

Paratek Pharmaceuticals Inc (NASDAQ: PRTK) was given a new $50.00 price target on by analysts at Cantor Fitzgerald. They now have a "buy" rating on the stock.

Paratek Pharmaceuticals, Inc.  (PRTK) 
Last paratek pharmaceuticals, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.paratekpharma.com